AltheRx Pharmaceuticals

AltheRx Pharmaceuticals specializes in premium domain sales, offering valuable online assets for branding and digital marketing needs. The company targets entrepreneurs and businesses seeking to enhance their online presence. AltheRx Pharmaceuticals, founded in 2010 in the US, focuses on the sale of premium domain names. The company has undergone no significant pivots in its business strategy.

It operates with a single known funding round, receiving a financing of USD 15 mn from Becker Ventures on May 2, 2013, which represents the total amount raised to date. Altherx. com offers the domain name "Altherx. com" for sale at USD 795 or via a payment plan of USD 33.

13 per month for 24 months. This service targets entrepreneurs, businesses, and individuals looking to establish a notable online presence across North America and Europe, enabling various applications such as branding, e-commerce, and digital marketing. Revenue for Altherx. com is generated through the sale of premium domain names, with clients able to purchase outright or finance via a structured payment plan.

The main offering is priced at USD 795, facilitating immediate access to the domain upon purchase through secure payment methods like PayPal and Escrow. com. This model emphasizes direct-to-consumer sales, catering to individual buyers and businesses seeking high-value digital assets. In May 2013, AltheRx Pharmaceuticals successfully secured USD 15 mn in financing from Becker Ventures.

The company plans to leverage these funds to enhance its offerings in premium domain sales, potentially introducing new domains designed for specific markets and expanding its reach to growth areas in Asia and South America by 2025.